|
Volumn 2, Issue 3, 2017, Pages 154-155
|
Direct-acting antiviral therapy for hepatitis E virus?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RIBAVIRIN;
RNA POLYMERASE;
SOFOSBUVIR;
ANTIVIRUS AGENT;
ANTIVIRAL THERAPY;
CHRONIC HEPATITIS;
HEPATITIS C VIRUS GENOTYPE 3;
HEPATITIS E VIRUS;
KIDNEY INJURY;
LETTER;
LIVER CIRRHOSIS;
MUTATION;
NONHUMAN;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
VIRUS REPLICATION;
CHRONIC HEPATITIS C;
COMBINATION DRUG THERAPY;
DRUG EFFECTS;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS E;
HUMAN;
VIRUS ACTIVATION;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C, CHRONIC;
HEPATITIS E;
HEPATITIS E VIRUS;
HUMANS;
VIRUS ACTIVATION;
|
EID: 85012257332
PISSN: 24681253
EISSN: None
Source Type: Journal
DOI: 10.1016/S2468-1253(16)30242-4 Document Type: Letter |
Times cited : (10)
|
References (5)
|